ERNA insider transaction filings
Ernexa Therapeutics Inc. — 10 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-02-17. Screen ERNA transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-17 | 4 | Cherington Charles — 10% owner | Purchase (P): 4,000,000 @ $0.50 · Purchase (P): 4,000,000 (derivative) | EDGAR |
| 2025-07-07 | 4 | Gurrola Sandra M — Sr. VP of Finance | Option exercise (M): 30 · Option exercise (M): 30 (derivative) @ $0 | EDGAR |
| 2025-06-11 | 4 | Cherington Charles — 10% owner | Purchase (P): 21,241,163 @ $0.10 | EDGAR |
| 2025-05-07 | 4/A | Cherington Charles — 10% owner | Purchase (P): 261,756 · Purchase (P): 4,768,783 · Purchase (P): 1,237,762 · Purchase (P): 5,420,823 · Purchase (P): 1,562,988 · Sale (S) · +4 more | EDGAR |
| 2025-04-04 | 4 | Cherington Charles — 10% owner | Purchase (P): 3,768,397 @ $0.10 | EDGAR |
| 2025-02-10 | 4 | Cicala Peter — Director | Grant/award (A): 51,485 (derivative) @ $0 | EDGAR |
| 2025-02-10 | 4 | Luther Sanjeev — President & CEO, Director | Grant/award (A): 1,123,350 (derivative) @ $0 | EDGAR |
| 2025-02-10 | 4 | Wexler William A. — Director | Grant/award (A): 124,533 (derivative) @ $0 | EDGAR |
| 2025-02-10 | 4 | Bristol James Arthur — Director | Grant/award (A): 72,074 (derivative) @ $0 | EDGAR |
| 2025-02-10 | 4 | Gurrola Sandra M — Sr. VP of Finance | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Ernexa Therapeutics Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-07-02 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-02 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-26 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-04 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-20 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2026-02-26 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-11 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-11 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-07-07 | 8-K | 4.01 — Changes in Registrant's Certifying Accountant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-12 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ERNA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →